| Original language | English (US) |
|---|---|
| Pages (from-to) | 481-482 |
| Number of pages | 2 |
| Journal | Obstetrical and Gynecological Survey |
| Volume | 72 |
| Issue number | 8 |
| DOIs |
|
| State | Published - Aug 1 2017 |
| Externally published | Yes |
ASJC Scopus subject areas
- Obstetrics and Gynecology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/gynecologic oncology group study. / Von Gruenigen, Vivian E.; Huang, Helen Q.; Beumer, Jan H. et al.
In: Obstetrical and Gynecological Survey, Vol. 72, No. 8, 01.08.2017, p. 481-482.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/gynecologic oncology group study
AU - Von Gruenigen, Vivian E.
AU - Huang, Helen Q.
AU - Beumer, Jan H.
AU - Lankes, Heather A.
AU - Tew, William
AU - Herzog, Thomas
AU - Hurria, Arti
AU - Mannel, Robert S.
AU - Rizack, Tina
AU - Landrum, Lisa M.
AU - Rose, Peter G.
AU - Salani, Ritu
AU - Bradley, William H.
AU - Rutherford, Thomas J.
AU - Higgins, Robert V.
AU - Secord, Angeles Alvarez
AU - Fleming, Gini
N1 - Funding Information: Division of Gynecologic Oncology, Summa Akron City Hospital, NEOMED, Akron, OH (V.E.v.G.); NRG Oncology Statistics & Data Center, Roswell Park Cancer Institute, Buffalo, NY (H.Q.H., H.A.L.); Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, and Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh (J.H.B.); Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine (J.H.B.), Pittsburgh, PA; Memorial Sloan Kettering Cancer Center, Department of Medicine, Gynecologic Medical Oncology Service (W.T.); Department of Obstetrics and Gynecology, Columbia University Cancer Center (T.H., A.H.), New York, NY; Division of Obstetrics & Gynecology, The Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK (R.S.M., L.M.L.); Department of Gynecologic Oncology, Women & Infants Hospital, Alpert Medical School of Brown University, Providence, RI (T.R.); Department of Gynecologic Oncology, Cleveland Clinic Foundation, Cleveland (P.G.R.); Department of Gynecologic Oncology, Ohio State University Medical Center, Columbus (R.S.), OH; Department of OB/GYN, Medical College of Wisconsin, Milwaukee, WI (W.H.B.); Department of OB/GYN, Western Connecticut Health Network, Norwalk, CT (T.J.R.); Department of Gynecologic Oncology, Carolinas Medical Center, Blumenthal Cancer Center, Charlotte (R.V.H.); Division of Gynecologic Oncology, Duke Cancer Institute (A.A.S.); Department of Obstetrics and Gynecology, Duke University Medical Center, Durham (A.A.S.), NC; and Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL (G.F.)
PY - 2017/8/1
Y1 - 2017/8/1
UR - http://www.scopus.com/inward/record.url?scp=85032301064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032301064&partnerID=8YFLogxK
U2 - 10.1097/01.ogx.0000524451.19814.73
DO - 10.1097/01.ogx.0000524451.19814.73
M3 - Comment/debate
AN - SCOPUS:85032301064
VL - 72
SP - 481
EP - 482
JO - Obstetrical and Gynecological Survey
JF - Obstetrical and Gynecological Survey
SN - 0029-7828
IS - 8
ER -